Site Search

Displaying results 441 - 450 of 519

ADAPTED

Alzheimer's disease apolipoprotein pathology for treatment elucidation and development

AMYPAD

Amyloid imaging to prevent Alzheimer’s disease

Closed IMI2 Neurodegenerative diseases Alzheimer's disease Clinical trial design Imaging

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Closed IMI2 Clinical trial design Patient involvement in R&D Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

PERISCOPE

PERtussIS COrrelates of Protection Europe

Ongoing IMI2 Infectious diseases Vaccines Conducting clinical trials

RHAPSODY

Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification

Closed IMI2 Diabetes & metabolic disorders Clinical trial design Disease taxonomy

VAC2VAC

Vaccine lot to vaccine lot comparison by consistency testing

Closed IMI2 Infectious diseases Vaccines 3Rs - animal use in research Regulatory and HTA processes

RADAR-CNS

Remote Assessment of Disease and Relapse in Central Nervous System Disorders

Closed IMI2 Psychiatric diseases Pain RADAR Digital health Big data and knowledge management

PRISM

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD

Closed IMI2 Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy Target identification Drug discovery

INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.

Ongoing IMI2 Diabetes & metabolic disorders Clinical trial design Disease taxonomy

ADAPT-SMART

Accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment-outcomes

Closed IMI2 Clinical trial design Real-world data, evidence Regulatory and HTA processes